Evidence map›Paper›PMID 36069546›Full record

ArticleJournal of virology2022

Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.

Danyel Evseev, Domingo Miranzo-Navarro, Ximena Fleming-Canepa, Robert G Webster, Katharine E Magor

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Danyel EvseevDepartment of Biological Sciences and Li Ka Shing Institute of Virology, University of Albertagrid.17089.37, Edmonton, Alberta, Canada.ORCID 0000-0002-0371-4987
Domingo Miranzo-NavarroDepartment of Biological Sciences and Li Ka Shing Institute of Virology, University of Albertagrid.17089.37, Edmonton, Alberta, Canada.ORCID 0000-0002-6876-7238
Ximena Fleming-CanepaDepartment of Biological Sciences and Li Ka Shing Institute of Virology, University of Albertagrid.17089.37, Edmonton, Alberta, Canada.ORCID 0000-0003-0986-3999
Robert G WebsterDivision of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-1899-1856
Katharine E MagorDepartment of Biological Sciences and Li Ka Shing Institute of Virology, University of Albertagrid.17089.37, Edmonton, Alberta, Canada.ORCID 0000-0002-9331-1486
University of Alberta · CASt. Jude Children's Research Hospital · US

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) MOP 125865HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) contract no. HHSN272201400006CNIAID NIH HHS HHSN272201400006C
6 · The paper itself

Abstract

The nonstructural protein 1 (NS1) of influenza A viruses is an important virulence factor that controls host cell immune responses. In human cells, NS1 proteins inhibit the induction of type I interferon by several mechanisms, including potentially, by preventing the activation of the retinoic acid-inducible gene I (RIG-I) receptor by the ubiquitin ligase tripartite motif-containing protein 25 (TRIM25). It is unclear whether the inhibition of human TRIM25 is a universal function of all influenza A NS1 proteins or is strain dependent. It is also unclear if NS1 proteins similarly target the TRIM25 of mallard ducks, a natural reservoir host of avian influenza viruses with a long coevolutionary history and unique disease dynamics. To answer these questions, we compared the ability of five different NS1 proteins to interact with human and duck TRIM25 using coimmunoprecipitation and microscopy and assessed the consequence of this on RIG-I ubiquitination and signaling in both species. We show that NS1 proteins from low-pathogenic and highly pathogenic avian influenza viruses potently inhibit RIG-I ubiquitination and reduce interferon promoter activity and interferon-beta protein secretion in transfected human cells, while the NS1 of the mouse-adapted PR8 strain does not. However, all the NS1 proteins, when cloned into recombinant viruses, suppress interferon in infected alveolar cells. In contrast, avian NS1 proteins do not suppress duck RIG-I ubiquitination and interferon promoter activity, despite interacting with duck TRIM25.

Indexed as

Avian ProteinsInfluenza A virusInfluenza in BirdsInterferon-betaReceptors, Retinoic AcidSignal TransductionViral Nonstructural ProteinsAnimalsAntiviral AgentsDucksHumansInterferon Type IMiceTripartite Motif ProteinsUbiquitinationAntiviral AgentsAvian ProteinsINS1 protein, influenza virusInterferon-betaInterferon Type IPLAAT4 protein, humanReceptors, Retinoic AcidTripartite Motif ProteinsViral Nonstructural Proteinsavian virusescell signalingduckinfluenza virusesinterferonsreservoir hostTRIM25ubiquitinationviral pathogenesis

Identifiers

PMID36069546
PMCPMC9517716
OpenAlexW4294917672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.